SCHEMBL28028516

SCHEMBL28028516

CCCC(C)(O)CF

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27548532 0.83
SCHEMBL28180755 0.81 FDPS (0.41)
SCHEMBL308585 0.81
SCHEMBL15844299 0.79 FDPS (0.43)
SCHEMBL16637518 0.79
SCHEMBL2820292 0.78 ALDH1A1 (0.41)
Phosphine SCHEMBL27893454 0.78 ALDH1A1 (0.41)
SCHEMBL1613219 0.78 ALDH1A1 (0.41)
Ammonia Solution, Strong SCHEMBL2097227 0.78 ALDH1A1 (0.41)
SCHEMBL1450906 0.77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103391928-B 1, 4-oxaza as BACE1 and/or BACE2 inhibitors HOFFMAN-LA ROCHE LTD. (CH) 2015-11-25 CN disclosed
CN-102958922-B 2,5,6,7-tetrahydrochysene-[Isosorbide-5-Nitrae] oxygen azepine *-3-base amine or 2,3,6,7-tetrahydrochysene-[Isosorbide-5-Nitrae] oxygen azepine *-5-ylamine compounds HOFFMAN-LA ROCHE LTD. (CH) 2015-09-30 CN disclosed